期刊文献+

超声引导下经直肠前列腺系统12点穿刺活检术对早期前列腺癌的诊断价值 被引量:3

Transrectal ultrasound-guided 12-core biopsy for early diagnosis of prostate cancer:A report of 149 cases
下载PDF
导出
摘要 目的评价经直肠超声引导下前列腺系统12点穿刺活检术的临床价值。方法对临床高度怀疑前列腺癌149例患者进行经直肠超声引导下前列腺系统12点穿刺活检。结果成功进行12点系统穿刺活检者149例,获取组织满意.病理诊断为前列腺癌36例,前列腺增生80例,不典型增生4例,前列腺内皮瘤4例,前列腺慢性炎症9例,鳞状上皮化生3例,结核1例。前列腺平滑肌肉瘤7例,前列腺囊肿5例。结论经直肠超声定位下系统12点穿刺法成功率高,无严重并发症。在临床早期诊断前列腺癌很有价值。 Objective To evaluate the clinical value of 12-core systemic prostate biopsy.Methods Prostatic puncture and biopsy guided by transrectal ultrasound was performed in 149 patients suspected of prostate cancer.Results 149 cases were under 12 cores transrectal ultrasound-guided biopsy.The histologic study confirmed 36 cases with prostate cancer,80 benign hyperplasia,4 atypical hyperplasia,4 endothelioma,9 chronic inflammation,3 squamous cellmetaplasia,1 tuberculosiswere,7 leiomyosarcoma and 5 cyst of prostate.Conclusion Transrectal ultrasound guided 12-core systemic prostate biopsy can improve prostate cancer detection rate with high success.No patient had severe complications after biopsy.It is useful in the early clinical diagnosis of prostate cancer.
作者 李波 宋永胜
出处 《实用临床医药杂志》 CAS 2011年第15期64-66,共3页 Journal of Clinical Medicine in Practice
关键词 经直肠超声 前列腺疾病 12点系统活检 transrectal ultrasound prostatic disease 12-core systemic biopsy
  • 相关文献

参考文献12

  • 1Jani A B,Johnstone P A,Liauw S L,et al.Age and grade trends in prostate cancer(1974-2003),a surveillance,epidemiology,and end results registry analysis[J].Am J Clinincol,2008,31(4):375. 被引量:1
  • 2Freed land SJ,Aronson W J,Terris MK,et al.Percent of prostate needle biopsycores with cancer is a significant independent predictor of PSA recurrence following radical prostatecto-my:results from the SEARCH Database[J].J Urol,2003,169(6):2136. 被引量:1
  • 3李欣,唐杰,汪娜,张彦,张舜欣,林倩.超声引导下穿刺标本中端粒酶逆转录酶活性检测对前列腺癌的诊断价值[J].中国超声医学杂志,2005,21(9):694-697. 被引量:2
  • 4彭瑛,沈国球.PSA动力学与前列腺癌的诊断及预后评估[J].华南国防医学杂志,2011,25(2):179-180. 被引量:1
  • 5胡望平,冯福英,叶桂云,肖少林,章宏斌,王海林,郑苗.血清c-PSA及C/T在提高前列腺癌诊断特异性中的探讨[J].第三军医大学学报,2007,29(18):1815-1817. 被引量:7
  • 6Presti J C,Chang J J,Bhargava V.The optimal systematic prostate biopsy scheme should included trather than biopsies:results of a prospective clinical trial[J].J Urol,2000,163(1):163. 被引量:1
  • 7Norberg M,Egevad 1,Holmberg L,et al.The sextant protocoL for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer[J].Urology,1997,50(4):562. 被引量:1
  • 8Davis M,Sofer M,Kim SS,et al.The procedure of TRUS guided biopsy of the prostate:a survey of patient preparation and biopsy technique[J].J Urol,2002,167(2):566. 被引量:1
  • 9Singh H,Canto E I,Shariat S F,et al.Imp roved detection of clinically significant,curable prostate cancer with systemat-ic12-core biospy[J].J U ol,2004,171(3):1089. 被引量:1
  • 10DeliveliotisC,VarkarkisJ,AlbanisS,etal.Biopsies of the transitional zone of the prostate[J].Should it be done on a routine basis,when and whyJ Urol,2002,68(2):113. 被引量:1

二级参考文献49

  • 1Rao AR, Motiwala HG, Karim OM. The discovery of prostate specific antigen[J]. BJU Int, 2008,101 ( 1 ) : 5-10. 被引量:1
  • 2Li J,Zhao G, Pollack IrA,el al. Use of the prostate-specific anti gen test among men aged 75 years or older in the United States 2006 Behavioral Risk Factor Surveillance System[J]. Prey Chron ic Dis,2010,7(4) : 84. 被引量:1
  • 3Rock RC, Chan DW, Bruzek D, et al. Evaluation of a monoclonal immunoradiometric assay for prostate specific antigen [J]. Clin Chem, 1987,33 (12) : 2257-2261. 被引量:1
  • 4Strope SA, Andriole GL. Prostate cancer screening: current sta tus and future perspectives[J]. Nat Rev Urol, 2010, 7(9): 487-493. 被引量:1
  • 5McDowell ME, Occhipinti S, Gardiner RA, et al. A review of prostate specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer[J]. Eur J Cancer Care, 2009,18(6): 545-555. 被引量:1
  • 6Cavadas V, Osorio L, Sabell F, et al. Prostate cancer prevention trial and European randomized study of screening for prostate cancer risk calculators: a performance comparison in a contempo rary screened cohort[J]. Eur Urol,2010,58(4):551-558. 被引量:1
  • 7Zelefsky MJ, Kattan MW, Feam P, el al. Pretreatment nomogram predicting ten year biochemical outcome of three-dimensional con-formal radiotherapy and intensity-modulated radiotherapy for prostate cancer[J]. Urology,2007,70(2):283-287. 被引量:1
  • 8Choueiri TK, Xie W, ErAmico AV, et al. Time to prostatespedfic mltigen nadir independently predicts overall survival in patients who have metastatic hormonesensitive prostate cancer treated with andro gen deprivation therapy[J]. Cancer, 2009,115 (5) : 981-987. 被引量:1
  • 9De Visschere P, Oosterlinck W, De Meerleer G, et al. Clinical and imaging tools in the early diagnosis of prostate cancer, a re view[J]. JBR-BTR,2010,93(2) :62-70. 被引量:1
  • 10de Crevoisier R, Slimane K, Messai T, et al. Early PSA decrease is an independent predictive factor of clinical failure and specificsurvival in patients with localized prostate cancer treated by radio: therapy with or without androgen deprivation therapy [J]. Ann 0ncol,2010,21 (4) :808-814. 被引量:1

共引文献29

同被引文献24

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部